US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2004052228
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: WO2004052228
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 7,547,435 | 2022-12-06 | ocriplasmin | Thrombogenics Inc. | JETREA |
| 7,914,783 | 2022-12-06 | ocriplasmin | Thrombogenics Inc. | JETREA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
